Comparison Between β-Emitting Isotopes and α-Emitters Regarding Their Effects on Cancer Cells
This paper starts with the argument that selectivity criteria require that proper radiation oncology, with only a few very specific exceptions, should be by radio-immunotherapy rather than by just radiation therapy. Radio-immunotherapy can be based on α-particles and β-particles as the cancer cell killing vector. In a subsequent chapter, the distinction between these two therapeutic concepts, based on their distinctive physical properties, are described. Then possibilities and the limitations for specific applications are presented based on the choice of isotope as the cell-killing vector and the choice of monoclonal antibody—or a modern alternative—as the cell-finding vector. For applications with β-emitters, the reader is referred to many examples described in the other papers in this handbook. For α-emitters, the feasibility of the various isotopes and isotope combinations are discussed. Finally, an illustration is given for a rough estimation of single patient dose requirements.
KeywordsRadiation Oncology Tumor Load Track Length Decay Cascade Source Isotope
- Bruland OS (2009) Clinical development of bone-seeking 223Ra (Alpharadin) current status. JNM 50(Suppl 2) abstract book 35 p 9PGoogle Scholar
- Hindorf C, Chittenden S et al (2009) Dosimetry for 223Ra and its daughters. JNM 50(Suppl 2) abstract book 102 p 27PGoogle Scholar
- Schwartz J, Jaspreet J et al (2009) Determination of kidney dose distributions using autoradiography and HpGe spectroscopy of kidney after injection of 225Ac-HuM195. JNM 50(Suppl 2) abstract book 37 p 10PGoogle Scholar
- Vaidyanathan G et al (2009) An astatine-222 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostat carcinoma. JNM 50(Suppl 2) abstract book 40 p 11PGoogle Scholar
- Wilbur D, Hamlin DK et al (2009) Isolation and protein labeling of t-21 from irradiated bismuth targets using a modified wet chemistry approach. JNM 50(Suppl 2) abstract book 99 p 26PGoogle Scholar